Status:
COMPLETED
Vitamin D, Bones, Nutritional and Cardiovascular Status
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Vitamin D
Eligibility:
All Genders
10-17 years
Phase:
NA
Brief Summary
Vitamin D is not seen anymore only as a phosphocalcic hormone, but also as having an effect on global health (anti-infective, anti-inflammatory, anti-tumour roles and cardiovascular protection). The ...
Detailed Description
To study the correlation between bone assessment by high-resolution peripheral quantitative computed tomography (HR-pQCT) and vitamin D serum concentration.
Eligibility Criteria
Inclusion
- 10 year-old \<or= Age \< 18 year-old
- Without mobility handicap (medical walker, crutch, wheelchair…)
- Written informed consent (signed by parents)
Exclusion
- History of treatment with growth hormone
- History of treatment with oral corticoids, taken over more than 3 consecutive months
- Current treatment with growth hormone, corticoids or anti-calcineurin
- Treatment with aspirin or nonsteroidal anti-inflammatory drug within the last three weeks
- Treatment with paracetamol within the last week
- Chronic pathology with an impact on growth:
- Parenteral nutrition
- Chronic inflammatory disease (rheumatologic or digestive notably)
- System diseases (lupus, granulomatosis, vascularitis)
- Renal failure
- Diabetes
- Serious intercurrent disease (infection, neoplasia)
- Ongoing pregnancy
- Patient unaffiliated with the French universal healthcare system.
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01832623
Start Date
February 1 2013
End Date
July 1 2016
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Femme Mère Enfant
Lyon, France, 69003